Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 14% Improvement Relative Risk c19early.org/c Majidi et al. Vitamin C for COVID-19 RCT ICU PATIENTS Is very late treatment with vitamin C beneficial for COVID-19? Double-blind RCT 100 patients in Iran (May - July 2020) Lower mortality with vitamin C (p=0.028) Majidi et al., Frontiers in Immunology, doi:10.3389/fimmu.2021.717816 Favors vitamin C Favors control
The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial
Majidi et al., Frontiers in Immunology, doi:10.3389/fimmu.2021.717816
Majidi et al., The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease.., Frontiers in Immunology, doi:10.3389/fimmu.2021.717816
Dec 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
RCT 100 ICU patients in Iran, 31 treated with vitamin C, showing lower mortality with treatment. IRCT20151226025699N5.
risk of death, 13.6% lower, RR 0.86, p = 0.03, treatment 26 of 31 (83.9%), control 67 of 69 (97.1%), NNT 7.6, day 28.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Majidi et al., 15 Dec 2021, Double Blind Randomized Controlled Trial, Iran, peer-reviewed, 16 authors, study period May 2020 - July 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Abstract: ORIGINAL RESEARCH published: 15 December 2021 doi: 10.3389/fimmu.2021.717816 The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial Nazanin Majidi 1, Faezeh Rabbani 2, Somayeh Gholami 3, Maryam Gholamalizadeh 4, Fatemeh BourBour 5, Samira Rastgoo 5, Azadeh Hajipour 6, Mahdi Shadnoosh 7, Mohammad Esmail Akbari 4, Bojlul Bahar 8, Narjes Ashoori 5, Atiyeh Alizadeh 9, Forough Samipoor 3, Alireza Moslem 10, Saeid Doaei 11* and Katsuhiko Suzuki 12* Edited by: Alberto Finamore, Council for Agricultural and Economics Research (CREA), Italy Reviewed by: Paul Ellis Marik, Eastern Virginia Medical School, United States Raffaella Comitato, Council for Agricultural and Economics Research (CREA), Italy *Correspondence: Saeid Doaei Sdoaee@yahoo.com Katsuhiko Suzuki katsu.suzu@waseda.jp Specialty section: This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Immunology Received: 31 May 2021 Accepted: 24 November 2021 Published: 15 December 2021 Citation: Majidi N, Rabbani F, Gholami S, Gholamalizadeh M, BourBour F, Rastgoo S, Hajipour A, Shadnoosh M, Akbari ME, Bahar B, Ashoori N, Alizadeh A, Samipoor F, Moslem A, Doaei S and Suzuki K (2021) The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial. Front. Immunol. 12:717816. doi: 10.3389/fimmu.2021.717816 1 Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran, 2 Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, 3 Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran, 4 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 5 Department of Clinical Nutrition and Dietetics, Research Institute Shahid Beheshti University of Medical Science, Tehran, Iran, 6 School of Health, Qazvin University of Medical Sciences, Qazvin, Iran, 7 Department of Clinical Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 8 Nutrition Sciences and Applied Food Safety Studies, Research Centre for Global Development, School of Sport & Health Sciences, University of Central Lancashire, Preston, United Kingdom, 9 Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran, 10 Department of Anesthesiology, Sabzevar University of Medical Sciences, Sabzevar, Iran, 11 Reproductive Health Research Center, Department of Obstetrics and Gynecology, School of Medicine, Al-Zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran, 12 Faculty of Sport Sciences, Waseda University, Tokorozawa, Japan Introduction: Vitamin C has been reported to have beneficial effects on patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate the effect of vitamin C supplementation on pathological parameters and survival duration of critically ill patients with COVID-19. Methods: This clinical trial was conducted on 120 hospitalized critically ill patients infected with COVID-19. The intervention group (n = 31) received one capsule of 500 mg of vitamin C daily for 14 days. The control group (n = 69) received the same nutrition except..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit